Literature DB >> 32144204

Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterol.

Hisako Akiyama1, Mitsuko Ide2, Yasuko Nagatsuka3, Tomoko Sayano3, Etsuro Nakanishi4, Norihito Uemura4, Kohei Yuyama5, Yoshiki Yamaguchi6, Hiroyuki Kamiguchi1, Ryosuke Takahashi4, Johannes M F G Aerts7, Peter Greimel8, Yoshio Hirabayashi9.   

Abstract

β-Glucocerebrosidase (GBA) hydrolyzes glucosylceramide (GlcCer) to generate ceramide. Previously, we demonstrated that lysosomal GBA1 and nonlysosomal GBA2 possess not only GlcCer hydrolase activity, but also transglucosylation activity to transfer the glucose residue from GlcCer to cholesterol to form β-cholesterylglucoside (β-GlcChol) in vitro β-GlcChol is a member of sterylglycosides present in diverse species. How GBA1 and GBA2 mediate β-GlcChol metabolism in the brain is unknown. Here, we purified and characterized sterylglycosides from rodent and fish brains. Although glucose is thought to be the sole carbohydrate component of sterylglycosides in vertebrates, structural analysis of rat brain sterylglycosides revealed the presence of galactosylated cholesterol (β-GalChol), in addition to β-GlcChol. Analyses of brain tissues from GBA2-deficient mice and GBA1- and/or GBA2-deficient Japanese rice fish (Oryzias latipes) revealed that GBA1 and GBA2 are responsible for β-GlcChol degradation and formation, respectively, and that both GBA1 and GBA2 are responsible for β-GalChol formation. Liquid chromatography-tandem MS revealed that β-GlcChol and β-GalChol are present throughout development from embryo to adult in the mouse brain. We found that β-GalChol expression depends on galactosylceramide (GalCer), and developmental onset of β-GalChol biosynthesis appeared to be during myelination. We also found that β-GlcChol and β-GalChol are secreted from neurons and glial cells in association with exosomes. In vitro enzyme assays confirmed that GBA1 and GBA2 have transgalactosylation activity to transfer the galactose residue from GalCer to cholesterol to form β-GalChol. This is the first report of the existence of β-GalChol in vertebrates and how β-GlcChol and β-GalChol are formed in the brain.
© 2020 Akiyama et al.

Entities:  

Keywords:  brain; cholesterol; galactosylated cholesterol; glucocerebrosidase; glycolipid; mass spectrometry (MS); sterol; sterylglycoside; transglycosylation; β-cholesterylgalactoside

Mesh:

Substances:

Year:  2020        PMID: 32144204      PMCID: PMC7170530          DOI: 10.1074/jbc.RA119.012502

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

Authors:  R O BRADY; J N KANFER; D SHAPIRO
Journal:  Biochem Biophys Res Commun       Date:  1965-01-18       Impact factor: 3.575

2.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

3.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Authors:  E Sidransky; M A Nalls; J O Aasly; J Aharon-Peretz; G Annesi; E R Barbosa; A Bar-Shira; D Berg; J Bras; A Brice; C-M Chen; L N Clark; C Condroyer; E V De Marco; A Dürr; M J Eblan; S Fahn; M J Farrer; H-C Fung; Z Gan-Or; T Gasser; R Gershoni-Baruch; N Giladi; A Griffith; T Gurevich; C Januario; P Kropp; A E Lang; G-J Lee-Chen; S Lesage; K Marder; I F Mata; A Mirelman; J Mitsui; I Mizuta; G Nicoletti; C Oliveira; R Ottman; A Orr-Urtreger; L V Pereira; A Quattrone; E Rogaeva; A Rolfs; H Rosenbaum; R Rozenberg; A Samii; T Samaddar; C Schulte; M Sharma; A Singleton; M Spitz; E-K Tan; N Tayebi; T Toda; A R Troiano; S Tsuji; M Wittstock; T G Wolfsberg; Y-R Wu; C P Zabetian; Y Zhao; S G Ziegler
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

4.  Separation and analysis of mono-glucosylated lipids in brain and skin by hydrophilic interaction chromatography based on carbohydrate and lipid moiety.

Authors:  Kazuki Nakajima; Hisako Akiyama; Kaori Tanaka; Ayako Kohyama-Koganeya; Peter Greimel; Yoshio Hirabayashi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-07-26       Impact factor: 3.205

5.  Diastereomer-specific quantification of bioactive hexosylceramides from bacteria and mammals.

Authors:  Johanna von Gerichten; Kerstin Schlosser; Dominic Lamprecht; Ivan Morace; Matthias Eckhardt; Dagmar Wachten; Richard Jennemann; Hermann-Josef Gröne; Matthias Mack; Roger Sandhoff
Journal:  J Lipid Res       Date:  2017-04-03       Impact factor: 5.922

6.  Identification of the non-lysosomal glucosylceramidase as beta-glucosidase 2.

Authors:  Rolf G Boot; Marri Verhoek; Wilma Donker-Koopman; Anneke Strijland; Jan van Marle; Hermen S Overkleeft; Tom Wennekes; Johannes M F G Aerts
Journal:  J Biol Chem       Date:  2006-11-14       Impact factor: 5.157

7.  The non-lysosomal β-glucosidase GBA2 is a non-integral membrane-associated protein at the endoplasmic reticulum (ER) and Golgi.

Authors:  Heinz G Körschen; Yildiz Yildiz; Diana Nancy Raju; Sophie Schonauer; Wolfgang Bönigk; Vera Jansen; Elisabeth Kremmer; U Benjamin Kaupp; Dagmar Wachten
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

8.  The HIV lipidome: a raft with an unusual composition.

Authors:  Britta Brügger; Bärbel Glass; Per Haberkant; Iris Leibrecht; Felix T Wieland; Hans-Georg Kräusslich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-15       Impact factor: 11.205

9.  Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death.

Authors:  Marcus Keatinge; Hai Bui; Aswin Menke; Yu-Chia Chen; Anna M Sokol; Qing Bai; Felix Ellett; Marc Da Costa; Derek Burke; Matthew Gegg; Lisa Trollope; Thomas Payne; Aimee McTighe; Heather Mortiboys; Sarah de Jager; Hugh Nuthall; Ming-Shang Kuo; Angeleen Fleming; Anthony H V Schapira; Stephen A Renshaw; J Robin Highley; Agnieszka Chacinska; Pertti Panula; Edward A Burton; Michael J O'Neill; Oliver Bandmann
Journal:  Hum Mol Genet       Date:  2015-09-16       Impact factor: 6.150

10.  Targeted mutagenesis using CRISPR/Cas system in medaka.

Authors:  Satoshi Ansai; Masato Kinoshita
Journal:  Biol Open       Date:  2014-04-11       Impact factor: 2.422

View more
  6 in total

1.  Impact of Gba2 on neuronopathic Gaucher's disease and α-synuclein accumulation in medaka (Oryzias latipes).

Authors:  Etsuro Nakanishi; Norihito Uemura; Hisako Akiyama; Masato Kinoshita; Sawamura Masanori; Yosuke Taruno; Hodaka Yamakado; Shu-Ichi Matsuzawa; Shunichi Takeda; Yoshio Hirabayashi; Ryosuke Takahashi
Journal:  Mol Brain       Date:  2021-05-10       Impact factor: 4.041

2.  Truncated mutants of beta-glucosidase 2 (GBA2) are localized in the mitochondrial matrix and cause mitochondrial fragmentation.

Authors:  Saki Sultana; Jacklyn Stewart; Aarnoud C van der Spoel
Journal:  PLoS One       Date:  2020-06-03       Impact factor: 3.240

3.  Structure, metabolism and biological functions of steryl glycosides in mammals.

Authors:  Michio Shimamura
Journal:  Biochem J       Date:  2020-11-13       Impact factor: 3.857

4.  Clinical and genetic characterization of a Taiwanese cohort with spastic paraparesis combined with cerebellar involvement.

Authors:  Min-Yu Lan; Chin-Song Lu; Shey-Lin Wu; Ying-Fa Chen; Yueh-Feng Sung; Min-Chien Tu; Yung-Yee Chang
Journal:  Front Neurol       Date:  2022-09-30       Impact factor: 4.086

Review 5.  Metabolism of Glycosphingolipids and Their Role in the Pathophysiology of Lysosomal Storage Disorders.

Authors:  Alex E Ryckman; Inka Brockhausen; Jagdeep S Walia
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

6.  Wild-type GBA1 increases the α-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice.

Authors:  Kelly E Glajch; Tim E Moors; Yi Chen; Pascal A Bechade; Alice Y Nam; Molly M Rajsombath; Thomas D McCaffery; Ulf Dettmer; Andreas Weihofen; Warren D Hirst; Dennis J Selkoe; Silke Nuber
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.